prazosin hydrochloride

Generic: prazosin hydrochloride

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name prazosin hydrochloride
Generic Name prazosin hydrochloride
Labeler aphena pharma solutions - tennessee, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

prazosin hydrochloride 5 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-829
Product ID 71610-829_18680839-460f-1189-e063-6394a90accdf
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214608
Listing Expiration 2026-12-31
Marketing Start 2023-01-17

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610829
Hyphenated Format 71610-829

Supplemental Identifiers

RxCUI
198141
UNII
X0Z7454B90

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name prazosin hydrochloride (source: ndc)
Generic Name prazosin hydrochloride (source: ndc)
Application Number ANDA214608 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 1250 CAPSULE in 1 BOTTLE (71610-829-27)
source: ndc

Packages (1)

Ingredients (1)

prazosin hydrochloride (5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "18680839-460f-1189-e063-6394a90accdf", "openfda": {"unii": ["X0Z7454B90"], "rxcui": ["198141"], "spl_set_id": ["18680157-a123-1072-e063-6394a90ad5ef"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "1250 CAPSULE in 1 BOTTLE (71610-829-27)", "package_ndc": "71610-829-27", "marketing_start_date": "20240510"}], "brand_name": "Prazosin Hydrochloride", "product_id": "71610-829_18680839-460f-1189-e063-6394a90accdf", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-829", "generic_name": "Prazosin Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Prazosin Hydrochloride", "active_ingredients": [{"name": "PRAZOSIN HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA214608", "marketing_category": "ANDA", "marketing_start_date": "20230117", "listing_expiration_date": "20261231"}